The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic Telangiectasia
In this multicenter retrospective cohort, IV bevacizumab therapy was associated with improved iron parameters and reduced transfusion requirements in patients with HHT-related bleeding.
Authors
- Serkan Güven
- Fatoş Dilan Köseoğlu
- Mehmet Turgut
- Ünal Ataş
- Öznur Aydın
- Sude Hatun Aktimur
- Hilmi Erdem Gözden
- Onur Şahin
- Derya Deniz Kürekci
- Selim Sayın
- Meltem Aylı
Institutions
- Izmir University (TR)
- Akdeniz University (TR)
- Ondokuz Mayıs University (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Canakkale Onsekiz Mart Universitesi Tip Fakultesi Hastanesi (TR)
- Samsun University (TR)
- S.B.Ü. Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Cureus
- Published
- 2026-01-27
- DOI
- https://doi.org/10.7759/cureus.102365
- Primary Topic
- Vascular Anomalies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00